Peter K. M. Verhaeghe

Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.

Merisant Co. is a holding company, which engages in the manufacture and market of tabletop sweeteners. Its flagship brands are Equal, Canderel, and Pure Via. The company was founded on March 20, 2000 and is headquartered in Chicago, IL.

KBC Private Equity Fund Biotech NV is a trading fund that focuses on life science companies. The company is in liquidation process. KBC Private Equity Fund Biotech was founded on March 10, 2001 and is headquartered Brussels, Belgium.

Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium.

Vermulst Verhaeghe & Graafsma is a private company based in Brussels, Belgium.

Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.

PharmaNeuroBoost NV operates as a drug development company for psychiatric disorders. The company was founded in 2006 and it is headquartered in Alken, Belgium